Update: 12.07.2022
Last week: 26 week 2022 (27.06.2022 - 03.07.2022)
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 123 490 | 83.0% | 5.8% | 2.5 | 24 317 924 | 76.0% | 5.3% | 2.2 | 3.6% |
| MoM | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| YTD | 5 971 890 | 45.3% | 6.0% | 1.1 | 1 181 197 530 | 73.6% | 5.7% | 1.4 | 17.8% |
| MAT | 15 131 366 | 62.6% | 6.8% | 2 | 2 791 503 298 | 92.9% | 6.3% | 2.1 | 14.6% |
| DEXALGIN | |||||||||
| WoW | 30 134 | 61.5% | 0.8% | 0.3 | 12 741 157 | 52.2% | 1.9% | 0.7 | 0.9% |
| MoM | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| YTD | 1 038 415 | 33.8% | 0.8% | 0.1 | 429 125 203 | 45.9% | 2.1% | 0.3 | 13.8% |
| MAT | 2 101 298 | 8.9% | 0.8% | 0 | 835 949 786 | 17.0% | 2.1% | 0.1 | 6.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 80 248 | 48.5% | 60.9% | 8.8 | 40 816 706 | 44.2% | 68.8% | 8 | 27.1% |
| MoM | 336 051 | -12.5% | 60.4% | -0.4 | 172 180 989 | -12.1% | 68.1% | 0.8 | -11.8% |
| YTD | 2 655 849 | 9.8% | 62.6% | -10.6 | 1 338 223 404 | 24.5% | 69.8% | -8.5 | 28.3% |
| MAT | 5 517 653 | 11.1% | 66.2% | -6 | 2 688 183 054 | 26.9% | 73.5% | -4.5 | 21.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 25 467 | 23.6% | 39.5% | 4.4 | 16 041 001 | 25.2% | 52.4% | 5.3 | 9.7% |
| MoM | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| YTD | 789 371 | -2.8% | 39.1% | -3 | 484 852 656 | 3.7% | 52.6% | -4.7 | 4.7% |
| MAT | 1 640 156 | -6.9% | 39.9% | -1 | 988 789 380 | 2.5% | 53.8% | -0.8 | -4.6% |
| FASTUM | |||||||||
| WoW | 18 749 | -0.3% | 1.0% | 0 | 9 874 795 | 1.0% | 2.3% | -0.1 | 3.6% |
| MoM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| YTD | 609 564 | -12.1% | 1.3% | -0.2 | 307 837 894 | -3.4% | 2.7% | -0.5 | 4.3% |
| MAT | 1 300 902 | -13.2% | 1.3% | -0.2 | 629 412 884 | -5.5% | 2.9% | -0.3 | 0.0% |
| IODOMARIN | |||||||||
| WoW | 53 951 | 3.8% | 20.6% | -0.2 | 11 097 889 | 2.6% | 9.4% | -0.2 | 4.6% |
| MoM | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| YTD | 1 501 571 | 12.5% | 18.3% | 0.1 | 303 559 579 | 21.4% | 8.3% | 0.1 | 12.2% |
| MAT | 3 333 823 | 20.0% | 20.5% | 2 | 645 960 567 | 22.1% | 9.3% | 0.6 | 8.5% |
| LIOTON | |||||||||
| WoW | 27 874 | 20.4% | 2.5% | 0.4 | 29 198 598 | 17.1% | 4.8% | 0.4 | 2.8% |
| MoM | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| YTD | 748 629 | -7.8% | 2.5% | -0.2 | 755 279 106 | 16.7% | 5.0% | -0.3 | -1.8% |
| MAT | 1 628 733 | -7.4% | 2.7% | -0.1 | 1 511 028 553 | 11.7% | 5.4% | -0.1 | -4.5% |
| MEZYM | |||||||||
| WoW | 318 024 | 62.7% | 27.7% | 7.9 | 48 324 175 | 59.2% | 19.3% | 5.5 | 16.2% |
| MoM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| YTD | 11 027 998 | 28.9% | 29.6% | 3.8 | 1 686 844 282 | 39.2% | 21.3% | 1.8 | 12.3% |
| MAT | 23 232 678 | 26.9% | 30.8% | 4.1 | 3 383 755 470 | 32.3% | 22.4% | 2 | 10.0% |
| MIG 400 | |||||||||
| WoW | 146 554 | 18.2% | 3.7% | 0.5 | 17 179 658 | 15.5% | 2.6% | 0.4 | 0.9% |
| MoM | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| YTD | 4 593 677 | 15.4% | 3.5% | 0 | 538 597 247 | 17.8% | 2.7% | -0.1 | 13.8% |
| MAT | 10 503 289 | 19.4% | 3.8% | 0.4 | 1 197 884 759 | 21.4% | 3.0% | 0.2 | 6.3% |
| PROSTAMOL | |||||||||
| WoW | 23 779 | 6.4% | 18.1% | 0.4 | 32 975 629 | 6.1% | 19.5% | 0.7 | 4.2% |
| MoM | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| YTD | 935 677 | -7.4% | 20.9% | -3.3 | 1 315 914 139 | 4.7% | 22.4% | -4.4 | 7.4% |
| MAT | 2 065 433 | -2.7% | 22.9% | -1.7 | 2 758 602 323 | 5.9% | 24.5% | -2.6 | 4.5% |
| RESPERO MYRTOL | |||||||||
| WoW | 11 535 | -13.5% | 7.1% | -0.9 | 5 464 682 | -14.0% | 6.9% | -0.9 | -2.6% |
| MoM | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
| YTD | 703 360 | 221.0% | 9.2% | 6 | 327 418 295 | 209.3% | 8.9% | 5.2 | 11.8% |
| MAT | 1 231 067 | 115.1% | 8.0% | 3.8 | 566 439 193 | 102.5% | 7.8% | 2.9 | 13.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 971 890 | 45.3% | 6.0% | 1.1 | 1 181 197 530 | 73.6% | 5.7% | 1.4 | 17.8% |
| DEXALGIN | 1 038 415 | 33.8% | 0.8% | 0.1 | 429 125 203 | 45.9% | 2.1% | 0.3 | 13.8% |
| ESPUMISAN (ADULTS) | 2 655 849 | 9.8% | 62.6% | -10.6 | 1 338 223 404 | 24.5% | 69.8% | -8.5 | 28.3% |
| ESPUMISAN BABY | 789 371 | -2.8% | 39.1% | -3 | 484 852 656 | 3.7% | 52.6% | -4.7 | 4.7% |
| FASTUM | 609 564 | -12.1% | 1.3% | -0.2 | 307 837 894 | -3.4% | 2.7% | -0.5 | 4.3% |
| IODOMARIN | 1 501 571 | 12.5% | 18.3% | 0.1 | 303 559 579 | 21.4% | 8.3% | 0.1 | 12.2% |
| LIOTON | 748 629 | -7.8% | 2.5% | -0.2 | 755 279 106 | 16.7% | 5.0% | -0.3 | -1.8% |
| MEZYM | 11 027 998 | 28.9% | 29.6% | 3.8 | 1 686 844 282 | 39.2% | 21.3% | 1.8 | 12.3% |
| MIG 400 | 4 593 677 | 15.4% | 3.5% | 0 | 538 597 247 | 17.8% | 2.7% | -0.1 | 13.8% |
| PROSTAMOL | 935 677 | -7.4% | 20.9% | -3.3 | 1 315 914 139 | 4.7% | 22.4% | -4.4 | 7.4% |
| RESPERO MYRTOL | 703 360 | 221.0% | 9.2% | 6 | 327 418 295 | 209.3% | 8.9% | 5.2 | 11.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 15 131 366 | 62.6% | 6.8% | 2 | 2 791 503 298 | 92.9% | 6.3% | 2.1 | 14.6% |
| DEXALGIN | 2 101 298 | 8.9% | 0.8% | 0 | 835 949 786 | 17.0% | 2.1% | 0.1 | 6.3% |
| ESPUMISAN (ADULTS) | 5 517 653 | 11.1% | 66.2% | -6 | 2 688 183 054 | 26.9% | 73.5% | -4.5 | 21.3% |
| ESPUMISAN BABY | 1 640 156 | -6.9% | 39.9% | -1 | 988 789 380 | 2.5% | 53.8% | -0.8 | -4.6% |
| FASTUM | 1 300 902 | -13.2% | 1.3% | -0.2 | 629 412 884 | -5.5% | 2.9% | -0.3 | 0.0% |
| IODOMARIN | 3 333 823 | 20.0% | 20.5% | 2 | 645 960 567 | 22.1% | 9.3% | 0.6 | 8.5% |
| LIOTON | 1 628 733 | -7.4% | 2.7% | -0.1 | 1 511 028 553 | 11.7% | 5.4% | -0.1 | -4.5% |
| MEZYM | 23 232 678 | 26.9% | 30.8% | 4.1 | 3 383 755 470 | 32.3% | 22.4% | 2 | 10.0% |
| MIG 400 | 10 503 289 | 19.4% | 3.8% | 0.4 | 1 197 884 759 | 21.4% | 3.0% | 0.2 | 6.3% |
| PROSTAMOL | 2 065 433 | -2.7% | 22.9% | -1.7 | 2 758 602 323 | 5.9% | 24.5% | -2.6 | 4.5% |
| RESPERO MYRTOL | 1 231 067 | 115.1% | 8.0% | 3.8 | 566 439 193 | 102.5% | 7.8% | 2.9 | 13.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 123 490 | 83.0% | 5.8% | 2.5 | 24 317 924 | 76.0% | 5.3% | 2.2 | 3.6% |
| DEXALGIN | 30 134 | 61.5% | 0.8% | 0.3 | 12 741 157 | 52.2% | 1.9% | 0.7 | 0.9% |
| ESPUMISAN (ADULTS) | 80 248 | 48.5% | 60.9% | 8.8 | 40 816 706 | 44.2% | 68.8% | 8 | 27.1% |
| ESPUMISAN BABY | 25 467 | 23.6% | 39.5% | 4.4 | 16 041 001 | 25.2% | 52.4% | 5.3 | 9.7% |
| FASTUM | 18 749 | -0.3% | 1.0% | 0 | 9 874 795 | 1.0% | 2.3% | -0.1 | 3.6% |
| IODOMARIN | 53 951 | 3.8% | 20.6% | -0.2 | 11 097 889 | 2.6% | 9.4% | -0.2 | 4.6% |
| LIOTON | 27 874 | 20.4% | 2.5% | 0.4 | 29 198 598 | 17.1% | 4.8% | 0.4 | 2.8% |
| MEZYM | 318 024 | 62.7% | 27.7% | 7.9 | 48 324 175 | 59.2% | 19.3% | 5.5 | 16.2% |
| MIG 400 | 146 554 | 18.2% | 3.7% | 0.5 | 17 179 658 | 15.5% | 2.6% | 0.4 | 0.9% |
| PROSTAMOL | 23 779 | 6.4% | 18.1% | 0.4 | 32 975 629 | 6.1% | 19.5% | 0.7 | 4.2% |
| RESPERO MYRTOL | 11 535 | -13.5% | 7.1% | -0.9 | 5 464 682 | -14.0% | 6.9% | -0.9 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| DEXALGIN | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| ESPUMISAN (ADULTS) | 336 051 | -12.5% | 60.4% | -0.4 | 172 180 989 | -12.1% | 68.1% | 0.8 | -11.8% |
| ESPUMISAN BABY | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| FASTUM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| IODOMARIN | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| LIOTON | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| MEZYM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| MIG 400 | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| PROSTAMOL | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| RESPERO MYRTOL | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 TABS TUNIC 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 TABS TUNIC 400 MG #10"
## [1] "MIG 400 TABS TUNIC 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs